| Bioactivity | JAK-IN-31 (Example 75) is a JAK inhibitor with IC50 ranges of ≤0.01µM, ≤0.01µM, 0.01-0.1 µM and ≤0.01µM for JAK1, JAK2, JAK3 and Tyk2 respectively. JAK-IN-31 can be used in cancer research[1]. |
| Name | JAK-IN-31 |
| CAS | 2597016-88-9 |
| Formula | C21H19N7O2S2 |
| Molar Mass | 465.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. David Randolph ANDERSON, et al. Substituted sulfonamide pyrrolopyridines as jak inhibitors. Patent WO2021022178A1. |